Arkolith/Insider Trading/MNPR/Form 4

Klausner Arthur J

DirectorMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$344K
Net Open-Market Flow
-$344K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Sell(S)5K$67.06$312K9K
Dec 18, 2025Sell(S)461$68.09$31K9K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-038426) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML